Literature DB >> 9685483

The Himar1 mariner transposase cloned in a recombinant adenovirus vector is functional in mammalian cells.

L Zhang1, U Sankar, D J Lampe, H M Robertson, F L Graham.   

Abstract

Mariner transposons belong to the mariner /Tc1 superfamily of class II, DNA-mediated elements. One of these transposons, Himar1 , isolated from the horn fly, is independent of host-specific factors that would limit transfer between different species, making it an ideal candidate for gene transfer technology development. To determine the activity of Himar1 transposase in mammalian cells, we introduced the Himar1 transposase gene into an adenovirus (Ad) vector under control of the phage T7 RNA polymerase promoter. Mammalian cells infected with the Ad vector carrying the Himar1 gene efficiently expressed the Himar1 transposase in the presence of T7 polymerase. In in vitro inter-plasmid transposition reactions, Himar1 transposase expressed by the Ad vector mediated precise cut-and-paste transposition and resulted in a characteristic duplication of TA at the integration site of the target plasmid. Further studies showed that this transposase was capable of catalyzing transposition between twoplasmids co-transfected into 293T7pol cells, which express T7 RNA polymerase. Combining the integration capability of mariner transposons with the transduction efficiency of Ad vectors is expected to provide a powerful tool for introducing transgenes into the host chromosome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685483      PMCID: PMC147766          DOI: 10.1093/nar/26.16.3687

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  36 in total

1.  P element transposition in vitro proceeds by a cut-and-paste mechanism and uses GTP as a cofactor.

Authors:  P D Kaufman; D C Rio
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

2.  Tn7 transposition in vitro proceeds through an excised transposon intermediate generated by staggered breaks in DNA.

Authors:  R Bainton; P Gamas; N L Craig
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

3.  Factors affecting transposition of the Himar1 mariner transposon in vitro.

Authors:  D J Lampe; T E Grant; H M Robertson
Journal:  Genetics       Date:  1998-05       Impact factor: 4.562

4.  Genetic evidence that Tn10 transposes by a nonreplicative mechanism.

Authors:  J Bender; N Kleckner
Journal:  Cell       Date:  1986-06-20       Impact factor: 41.582

5.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Site-specific integration by adeno-associated virus.

Authors:  R M Kotin; M Siniscalco; R J Samulski; X D Zhu; L Hunter; C A Laughlin; S McLaughlin; N Muzyczka; M Rocchi; K I Berns
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

8.  A recombinant human adenovirus vaccine against rabies.

Authors:  L Prevec; J B Campbell; B S Christie; L Belbeck; F L Graham
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

9.  Evidence for Drosophila P element transposase activity in mammalian cells and yeast.

Authors:  D C Rio; G Barnes; F A Laski; J Rine; G M Rubin
Journal:  J Mol Biol       Date:  1988-03-20       Impact factor: 5.469

10.  Targeted integration of adeno-associated virus (AAV) into human chromosome 19.

Authors:  R J Samulski; X Zhu; X Xiao; J D Brook; D E Housman; N Epstein; L A Hunter
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  18 in total

1.  cis and trans factors affecting Mos1 mariner evolution and transposition in vitro, and its potential for functional genomics.

Authors:  L R Tosi; S M Beverley
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  Construction of a Vibrio cholerae vaccine candidate using transposon delivery and FLP recombinase-mediated excision.

Authors:  S L Chiang; J J Mekalanos
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

3.  Comprehensive identification of conditionally essential genes in mycobacteria.

Authors:  C M Sassetti; D H Boyd; E J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

4.  Towards integrating vectors for gene therapy: expression of functional bacteriophage MuA and MuB proteins in mammalian cells.

Authors:  F H Schagen; H J Rademaker; S J Cramer; H van Ormondt; A J van der Eb; P van de Putte; R C Hoeben
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

5.  Development of a mariner-based transposon for use in Sorangium cellulosum.

Authors:  Bryan Julien; Ruby Fehd
Journal:  Appl Environ Microbiol       Date:  2003-10       Impact factor: 4.792

Review 6.  Transposon tools hopping in vertebrates.

Authors:  Jun Ni; Karl J Clark; Scott C Fahrenkrug; Stephen C Ekker
Journal:  Brief Funct Genomic Proteomic       Date:  2008-11

7.  Hyperactive transposase mutants of the Himar1 mariner transposon.

Authors:  D J Lampe; B J Akerley; E J Rubin; J J Mekalanos; H M Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

8.  An Engineered Cas-Transposon System for Programmable and Site-Directed DNA Transpositions.

Authors:  Sway P Chen; Harris H Wang
Journal:  CRISPR J       Date:  2019-11-19

9.  Genome-wide insertional mutagenesis in human cells by the Drosophila mobile element Minos.

Authors:  A G Klinakis; L Zagoraiou; D K Vassilatis; C Savakis
Journal:  EMBO Rep       Date:  2000-11       Impact factor: 8.807

10.  In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria.

Authors:  E J Rubin; B J Akerley; V N Novik; D J Lampe; R N Husson; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.